vx 497 has been researched along with Adjuvant Arthritis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barrish, JC; Bednarz, MS; Berry, KK; Chen, BC; Cheney, DL; Dhar, TG; Fleener, CA; Gu, HH; Guo, J; Harper, TW; Hollenbaugh, DL; Iwanowicz, EJ; Liu, C; MacMaster, JF; McIntyre, KW; Miller, LM; Pitts, WJ; Rouleau, KA; Shen, Z; Sherbina, NZ; Shuster, DJ; Tredup, JA; Watterson, SH; Witmer, MR; Zhao, R | 1 |
1 other study(ies) available for vx 497 and Adjuvant Arthritis
Article | Year |
---|---|
Discovery of N-[2-[2-[[3-methoxy-4-(5-oxazolyl)phenyl]amino]-5-oxazolyl]phenyl]-N-methyl-4- morpholineacetamide as a novel and potent inhibitor of inosine monophosphate dehydrogenase with excellent in vivo activity.
Topics: Animals; Antibody Formation; Arthritis, Experimental; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; IMP Dehydrogenase; Male; Mice; Mice, Inbred BALB C; Morpholines; Mycophenolic Acid; Oxazoles; Rats; Rats, Inbred Lew; Structure-Activity Relationship | 2002 |